menu
    • menu

    Company profile for Endevica Bio

    NEW Drugs in Dev: 3
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Endevica Bio's lead drug candidate is a peptide therapeutic for treating cachexia due to cancer and other chronic conditions. The company was formed in 2009 to create best in class peptide drug candidates with better safety and efficacy properties than other drugs in the same class.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Endevica BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1601 S. Providence Rd. Columbia, MO 65211 USA
    Telephone
    Telephone
    (573) 881-5080
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://endevicabio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ICMD China

    ICMD China

    Not Confirmed

    envelop Contact Supplier

    ICMD China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Endevica Spins Out Kalohexis for Melanocortin Obesity Drugs
    Endevica Spins Out Kalohexis for Melanocortin Obesity Drugs

    19 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/endevica-announces-spinout-of-kalohexis-to-advance-first--and-best-in-class-therapeutics-harnessing-the-melanocortin-system-to-treat-obesity-and-metabolic-diseases-302718317.html

    PR NEWSWIRE
    19 Mar 2026
    Share Share
    Endevica Bio Starts Phase 2 Trial in Stage 4 Colorectal Cancer
    Endevica Bio Starts Phase 2 Trial in Stage 4 Colorectal Cancer

    17 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/endevica-bio-announces-first-patient-dosing-in-phase-2-trial-in-patients-with-stage-4-metastatic-colorectal-cancer-302431924.html

    PR NEWSWIRE
    17 Apr 2025
    Share Share
    Endevica Bio to Start Ph 2 Trial for Weight Loss in Cancer Patients
    Endevica Bio to Start Ph 2 Trial for Weight Loss in Cancer Patients

    20 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/endevica-bio-to-start-phase-2-clinical-trial-of-drug-to-prevent-weight-loss-in-cancer-patients-302336946.html

    PR NEWSWIRE
    20 Dec 2024
    Share Share
    Endevica Bio Spins Off New Company to Develop Weight Loss Drug
    Endevica Bio Spins Off New Company to Develop Weight Loss Drug

    01 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/endevica-bio-spins-off-new-company-to-develop-weight-loss-drug-302294209.html

    PR NEWSWIRE
    01 Nov 2024
    Share Share
    Endevica Bio drug candidate shows success in weight loss in new study
    Endevica Bio drug candidate shows success in weight loss in new study

    23 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/endevica-bio-drug-candidate-shows-success-in-weight-loss-in-new-study-302124298.html

    PR NEWSWIRE
    23 Apr 2024
    Share Share
    Orbit and Endevica Enter Collaboration for Cachexia Therapeutics
    Orbit and Endevica Enter Collaboration for Cachexia Therapeutics

    01 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230201005470/en

    BUSINESSWIRE
    01 Feb 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search